Effect of geranylgeranylacetone on optic neuritis in experimental autoimmune encephalomyelitis

Neuroscience Letters

Volumn 462, Issue 3, 2009, Pages 281-285

  Guo, Xiaoli ^a   Harada, Chikako ^a   Namekata, Kazuhiko ^a   Kikushima, Kenji ^a   Mitamura, Yoshinori ^b   Yoshida, Hiroshi ^c   Matsumoto, Yoh ^a   Harada, Takayuki ^a,c  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c TOKYO METROPOLITAN NEUROLOGICAL HOSPITAL   (Japan)

Author keywords

Experimental autoimmune encephalomyelitis; Multiple sclerosis; Neuroprotection; Optic neuritis

Indexed keywords

MYELIN OLIGODENDROCYTE GLYCOPROTEIN; TEPRENONE;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL LOSS; CLINICAL FEATURE; CONTROLLED STUDY; DEMYELINATION; DISEASE SEVERITY; DRUG EFFECT; ELECTRORETINOGRAM; FEMALE; MORPHOLOGY; MOUSE; MULTIPLE SCLEROSIS; NERVE FIBER DEGENERATION; NEUROPROTECTION; NONHUMAN; OPTIC NERVE; OPTIC NEURITIS; PRIORITY JOURNAL; RETINA GANGLION CELL; VISUAL SYSTEM FUNCTION;

ANIMALS; AXONS; DITERPENES; ELECTRORETINOGRAPHY; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; MICE; MICE, INBRED C57BL; MYELIN-ASSOCIATED GLYCOPROTEIN; OPTIC NERVE; OPTIC NEURITIS;

EID: 67849093970     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.07.028     Document Type: Article

References (33)

1. Berger T., Weerth S., Kojima K., Linington C., Wekerle H., and Lassmann H. Experimental autoimmune encephalomyelitis: the antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system. Lab. Invest. 76 (1997) 355-364
2. Birnbaum G., and Kotilinek L. Immunity to heat shock proteins and neurological disorders of women. Infect. Dis. Obstet. Gynecol. 7 (1999) 39-48
3. Fujiki M., Furukawa Y., Kobayashi H., Abe T., Ishii K., Uchida S., and Kamida T. Geranylgeranylacetone limits secondary injury, neuronal death, and progressive necrosis and cavitation after spinal cord injury. Brain Res. 1053 (2005) 175-184
4. Fujiki M., Hikawa T., Abe T., Uchida S., Morishige M., Sugita K., and Kobayashi H. Role of protein kinase C in neuroprotective effect of geranylgeranylacetone, a noninvasive inducing agent of heat shock protein, on delayed neuronal death caused by transient ischemia in rats. J. Neurotrauma 23 (2006) 1164-1178
5. Gilgun-Sherki Y., Melamed E., and Offen D. The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy. J. Neurol. 251 (2004) 261-268
6. Greer J.M., Kuchroo V.K., Sobel R.A., and Lees M.B. Identification and characterization of a second encephalitogenic determinant of myelin proteolipid protein (residues 178-191) for SJL mice. J. Immunol. 149 (1992) 783-788
7. Greer J.M., Sobel R.A., Sette A., Southwood S., Lees M.B., and Kuchroo V.K. Immunogenic and encephalitogenic epitope clusters of myelin proteolipid protein. J. Immunol. 156 (1996) 371-379
8. Guo X., Nakamura K., Kohyama K., Harada C., Behanna H.A., Watterson D.M., Matsumoto Y., and Harada T. Inhibition of glial cell activation ameliorates the severity of experimental autoimmune encephalomyelitis. Neurosci. Res. 59 (2007) 457-466
9. Harada C., Nakamura K., Namekata K., Okumura A., Mitamura Y., Iizuka Y., Kashiwagi K., Yoshida K., Ohno S., Matsuzawa A., Tanaka K., Ichijo H., and Harada T. Role of apoptosis signal-regulating kinase 1 in stress-induced neural cell apoptosis in vivo. Am. J. Pathol. 168 (2006) 261-269
10. Harada C., Nakamura K., Guo X., Kitaichi N., Mitamura Y., Yoshida K., Ohno S., Yoshida H., and Harada T. Neuroprotective effect of geranylgeranylacetone against ischemia-induced retinal injury. Mol. Vis. 13 (2007) 1601-1607
11. Harada T., Ohashi T., Fukazawa T., Miyagishi R., Moriwaka F., Chin S., Yoshida K., and Matsuda H. Visual function in patients with optic neuritis associated with acute transverse myelopathy in multiple sclerosis. Jpn. J. Ophthalmol. 39 (1995) 290-294
12. Harada T., Harada C., Nakamura K., Quah H.A., Okumura A., Namekata K., Saeki T., Aihara M., Yoshida H., Mitani A., and Tanaka K. The potential role of glutamate transporters in the pathogenesis of normal tension glaucoma. J. Clin. Invest. 117 (2007) 1763-1770
13. Hasegawa S., Ohshima A., Hayakawa Y., Takagi M., and Abe H. Multifocal electroretinograms in patients with branch retinal artery occlusion. Invest. Ophthalmol. Vis. Sci. 42 (2001) 298-304
14. Hickman S.J., Dalton C.M., Miller D.H., and Plant G.T. Management of acute optic neuritis. Lancet 60 (2002) 1953-1962
15. Hirota K., Nakamura H., Arai T., Ishii H., Bai J., Itoh T., Fukuda K., and Yodoi J. Geranylgeranylacetone enhances expression of thioredoxin and suppresses ethanol-induced cytotoxicity in cultured hepatocytes. Biochem. Biophys. Res. Commun. 275 (2000) 825-830
16. Ichijo H., Nishida E., Irie K., ten Dijke P., Saitoh M., Moriguchi T., Takagi M., Matsumoto K., Miyazono K., and Gotoh Y. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 275 (1997) 90-94
17. Ishii Y., Kwong J.M., and Caprioli J. Retinal ganglion cell protection with geranylgeranylacetone, a heat shock protein inducer, in a rat glaucoma model. Invest. Ophthalmol. Vis. Sci. 44 (2003) 1982-1992
18. Jarius S., Paul F., Franciotta D., Waters P., Zipp F., Hohlfeld R., Vincent A., and Wildemann B. Mechanisms of Disease: aquaporin-4 antibodies in neuromyelitis optica. Nat. Clin. Pract. Neurol. 4 (2008) 202-214
19. Katsuno M., Sang C., Adachi H., Minamiyama M., Waza M., Tanaka F., Doyu M., and Sobue G. Pharmacological induction of heat-shock proteins alleviates polyglutamine-mediated motor neuron disease. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 16801-16806
20. Matiello M., Lennon V.A., Jacob A., Pittock S.J., Lucchinetti C.F., Wingerchuk D.M., and Weinshenker B.G. NMO-IgG predicts the outcome of recurrent optic neuritis. Neurology 70 (2008) 2197-2200
21. Matsuzawa A., and Ichijo H. Stress-responsive protein kinases in redox-regulated apoptosis signaling. Antioxid. Redox Signal. 7 (2005) 472-481
22. Mendel I., de Rosbo N., Kerlero A., and Ben-Nun. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells. Eur. J. Immunol. 25 (1995) 1951-1959
23. Nagai Y., Fujiki M., Inoue R., Uchida S., Abe T., Kobayashi H., and Cetinalp N.E. Neuroprotective effect of geranylgeranylacetone, a noninvasive heat shock protein inducer, on cerebral infarction in rats. Neurosci. Lett. 374 (2005) 183-188
24. Ooie T., Takahashi N., Saikawa T., Nawata T., Arikawa M., Yamanaka K., Hara M., Shimada T., and Sakata T. Single oral dose of geranylgeranylacetone induces heat-shock protein 72 and renders protection against ischemia/reperfusion injury in rat heart. Circulation 104 (2001) 1837-1843
25. Park H.S., Cho S.G., Kim C.K., Hwang H.S., Noh K.T., Kim M.S., Huh S.H., Kim M.J., Ryoo K., Kim E.K., Kang W.J., Lee J.S., Seo J.S., Ko Y.G., Kim S., and Choi E.J. Heat shock protein hsp72 is a negative regulator of apoptosis signal-regulating kinase 1. Mol. Cell Biol. 22 (2002) 7721-7730
26. Ralay Ranaivo H., Craft J.M., Hu W., Guo L., Wing L.K., Van Eldik L.J., and Watterson D.M. Glia as a therapeutic target: selective suppression of human amyloid-β-induced upregulation of brain proinflammatory cytokine production attenuates neurodegeneration. J. Neurosci. 26 (2006) 662-670
27. Schreibelt G., van Horssen J., van Rossum S., Dijkstra C.D., Drukarch B., and de Vries H.E. Therapeutic potential and biological role of endogenous antioxidant enzymes in multiple sclerosis pathology. Brain Res. Rev. 56 (2007) 322-330
28. Suzuki S., Maruyama S., Sato W., Morita Y., Sato F., Miki Y., Kato S., Katsuno M., Sobue G., Yuzawa Y., and Matsuo S. Geranylgeranylacetone ameliorates ischemic acute renal failure via induction of Hsp70. Kidney Int. 67 (2005) 2210-2220
29. Tanito M., Kwon Y.W., Kondo N., Bai J., Masutani H., Nakamura H., Fujii J., Ohira A., and Yodoi J. Cytoprotective effects of geranylgeranylacetone against retinal photooxidative damage. J. Neurosci. 25 (2005) 2396-2404
30. Tuohy V.K., Lu Z., Sobel R.A., Laursen R.A., and Lees M.B. Identification of an encephalitogenic determinant of myelin proteolipid protein for SJL mice. J. Immunol. 142 (1989) 1523-1527
31. Uchida S., Fujiki M., Nagai Y., Abe T., Kobayashi H., and Geranylgeranylacetone. a noninvasive heat shock protein inducer, induces protein kinase C and leads to neuroprotection against cerebral infarction in rats. Neurosci. Lett. 396 (2006) 220-224
32. Yasuda H., Shichinohe H., Kuroda S., Ishikawa T., and Iwasaki Y. Neuroprotective effect of a heat shock protein inducer, geranylgeranylacetone in permanent focal cerebral ischemia. Brain Res. 1032 (2005) 176-182
33. Zamvil S.S., Mitchell D.J., Moore A.C., Kitamura K., Steinman L., and Rothbard J.B. T-cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis. Nature 324 (1986) 258-260